Ratio Analysis - Speciality Medicines Ltd.
Search Company
You can view Income Statement for the last 5 years.
ISIN No INE404B01022 52Wk High (Rs.) 26 BV (Rs.) 10.99 FV (Rs.) 1.00
Bookclosure 23/09/2025 52Wk Low (Rs.) 3 EPS (Rs.) 0.44 P/E (X) 16.38
Mkt Cap. (Rs. Cr.) 252.86 P/BV (X) 0.65 Div Yield (%) 0.28 Mkt Lot 1
Standalone Consolidated
(Rs. in Crs.)
ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue1.0010.0010.0010.0010.00
      
      
INCOME     
Revenue From Operations [Net]30.210.2350.000.000.00
Total Operating Revenues30.210.2350.000.000.00
      
Other Income14.553.503.202.515.00
Total Revenue44.763.7353.202.515.00
      
EXPENSES     
Cost Of Materials Consumed1.810.970.000.000.60
Purchase Of Stock-In Trade10.160.000.070.000.00
Changes In Inventories Of FG,WIP And Stock-In Trade-0.15-0.92-0.21-0.17-0.75
Employee Benefit Expenses0.820.310.070.060.06
Finance Costs1.040.210.830.520.99
Depreciation And Amortisation Expenses0.470.220.220.220.22
Other Expenses16.621.5345.150.190.18
Total Expenses30.772.3246.120.811.29
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax13.991.417.081.703.70
      
Profit/Loss Before Tax13.991.417.081.703.70
      
Tax Expenses-Continued Operations     
Current Tax3.450.382.500.000.00
Deferred Tax-0.030.000.000.000.02
Tax For Earlier Years-0.010.000.000.000.00
Total Tax Expenses3.400.382.500.000.02
Profit/Loss After Tax And Before ExtraOrdinary Items10.591.034.581.703.68
      
Profit/Loss From Continuing Operations10.591.034.581.703.68
      
Profit/Loss For The Period10.591.034.581.703.68
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)0.300.613.921.463.15
Diluted EPS (Rs.)0.300.613.921.463.15
      
DIVIDEND AND DIVIDEND PERCENTAGE     
Equity Share Dividend0.580.330.000.000.00
Equity Dividend Rate (%)2.002.502.500.000.00